A NEW ORAL LESION IDENTIFICATION AND MARKING SYSTEM AdDent presents the OraBlu Lesion Marking System. An easy to use adjunct for screening suspected oral cancer lesions. This marking system is designed to enhance the visualization of suspicious lesions and mucosal irregularities. Commonly known as Toluidine Blue, the stain is a significant help in determining the need for biopsy, and possibly saves lives with a timely diagnosis. OraBlu is designed to be used with an oral screening device manufactured by AdDent. AdDent, Inc. 43 miry brook road, danbury, Connecticut 06810 TEL: 203.778.0200 | FAX: 203.792.2275 | [email protected] | WWW.ADDENT.COM AdDent is an ISO 9001 certified & ISO 13485 compliant company.

- 42,000 Americans will be diagnosed with oral or pharyngeal cancer in 2013 - 8,000 Americans will die of oral or pharyngeal cancer in 2013 - 43% of those with oral or pharyngeal cancer will die within 5 years of initial diagnosis - 1 American dies every hour of oral or pharyngeal cancer "In conclusion toluidine blue stain has been shown to be a reliable aid when clinical examination is unable to differentiate lesions at high risk of progression and then it improves early diagnosis for oral cavity and oropharyngeal cancer" - Allegra E, Lombardo N., Puzzo L., Earozzo A. Acta Otorhinolaryngol Ital....